ARS Pharmaceuticals, Inc. (SPRY) › Cost of RevenueARS Pharmaceuticals, Inc. (SPRY) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearCost of RevenueChange YoY2023$0—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share